These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29298329)

  • 1. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance.
    Abou-Antoun TJ; Nazarian J; Ghanem A; Vukmanovic S; Sandler AD
    PLoS One; 2018; 13(1):e0189711. PubMed ID: 29298329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression.
    Rached J; Nasr Z; Abdallah J; Abou-Antoun T
    Int J Oncol; 2016 Oct; 49(4):1722-30. PubMed ID: 27432152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma.
    Chakrabarti L; Wang BD; Lee NH; Sandler AD
    PLoS One; 2013; 8(12):e83521. PubMed ID: 24376712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
    Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
    Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance.
    Chakrabarti L; Abou-Antoun T; Vukmanovic S; Sandler AD
    Front Oncol; 2012; 2():82. PubMed ID: 22891161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential.
    Domenichini A; Edmands JS; Adamska A; Begicevic RR; Paternoster S; Falasca M
    Adv Biol Regul; 2019 May; 72():63-77. PubMed ID: 30853342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.
    Piskareva O; Harvey H; Nolan J; Conlon R; Alcock L; Buckley P; Dowling P; Henry M; O'Sullivan F; Bray I; Stallings RL
    Cancer Lett; 2015 Aug; 364(2):142-55. PubMed ID: 25960282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
    Chen Y; Tsai YH; Tseng SH
    Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
    Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
    Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRPM7 interactome defines a cytoskeletal complex linked to neuroblastoma progression.
    Middelbeek J; Vrenken K; Visser D; Lasonder E; Koster J; Jalink K; Clark K; van Leeuwen FN
    Eur J Cell Biol; 2016 Nov; 95(11):465-474. PubMed ID: 27402209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
    Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
    Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.
    Rodríguez-Hernández CJ; Mateo-Lozano S; García M; Casalà C; Briansó F; Castrejón N; Rodríguez E; Suñol M; Carcaboso AM; Lavarino C; Mora J; de Torres C
    Oncotarget; 2016 Mar; 7(13):16112-29. PubMed ID: 26893368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.
    Wang M; Liu Y; Zou J; Yang R; Xuan F; Wang Y; Gao N; Cui H
    Oncotarget; 2015 Apr; 6(11):9517-30. PubMed ID: 25940705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model.
    Cao D; Kishida S; Huang P; Mu P; Tsubota S; Mizuno M; Kadomatsu K
    PLoS One; 2014; 9(1):e86813. PubMed ID: 24466252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
    Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
    Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo.
    Hossain S; Takatori A; Nakamura Y; Suenaga Y; Kamijo T; Nakagawara A
    Cancer Res; 2012 Sep; 72(17):4587-96. PubMed ID: 22815527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
    J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.